logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

J. David Smeijer

University of Groningen

7H-index
24Paper Count
209Citation Count
Published Papers 9
Publication Date
logo
Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-05-21
err0
errOAAI
errVictor Wasehuus MD; J. David Smeijer MD; Phil Ambery MD; Peter J. Greasley PhD; Emma Wijkmark MSc; David C. Wheeler MD; Peter Rossing DMSc
errShare
errSave
Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial
errDIABETOLOGIA
IF10.2
err2024-12-11
err0
PREAI
errSmeijer, J. David; de Vries, Sieta T.; Kohan, Donald E.; Hou, Fan Fan; Heerspink, Hiddo J. L.
errShare
errSave
Endothelin receptor antagonists in chronic kidney disease
errNATURE REVIEWS NEPHROLOGY
IF39.8
err2024-12-06
err0
PREAI
errSmeijer, J. David; Kohan, Donald E.; Dhaun, Neeraj; Noronha, Irene L.; Liew, Adrian; Heerspink, Hiddo J. L.
errShare
errSave
The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-11-06
err0
errOAAI
errSmeijer, Johannes David; Gomez, Maria F.; Rossing, Peter; Heerspink, Hiddo J. L.
errShare
errSave
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease
errKIDNEY INTERNATIONAL
IF12.6
err2023-12-01
err8
errOAAI
errChan, Kam Wa; Smeijer, J. David; Schechter, Meir; Jongs, Niels; Vart, Priya; Kohan, Donald E.; Gansevoort, Ron T.; Liew, Adrian; Tang, Sydney C. W.; Wanner, Christoph; de Zeeuw, Dick; Heerspink, Hiddo J. L.
errShare
errSave
Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2023-09-16
err13
errOAAI
errSmeijer, J. David; Kohan, Donald E.; Rossing, Peter; Correa-Rotter, Ricardo; Liew, Adrian; Tang, Sydney C. W.; de Zeeuw, Dick; Gansevoort, Ron T.; Ju, Wenjun; Heerspink, Hiddo J. Lambers
errShare
errSave
Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-05-08
err0
errOAAI
errSmeijer, J. David; Kohan, Donald E.; de Zeeuw, D.; Heerspink, Hiddo J. L.
errShare
errSave
Organic Anion Transporter Gene Variants Associated with Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2022-08-11
err4
errOAAI
errSmeijer, J. David; Koomen, Jeroen, V; Kohan, Donald E.; McMurray, John J., V; Bakris, George L.; Correa-Rotter, Ricardo; Hou, Fan-Fan; Kitzman, Dalane W.; Makino, Hirofumi; Mayer, Gert; Nowicki, Michal; Perkovic, Vlado; Rossing, Peter; Tobe, Sheldon; Parving, Hans-Henrik; de Zeeuw, Dick; Heerspink, Hiddo J. L.
errShare
errSave
Enlarged Perivascular Spaces and Dementia: A Systematic Review
errJOURNAL OF ALZHEIMERS DISEASE
IF3.1
err2019-10-29
err38
errOAAI
errSmeijer, David; Ikram, M. Kamran; Hilal, Saima
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
John J.V. McMurray
H-index: 231 · Papers: 2.6K
G
George L. Bakris
H-index: 147 · Papers: 1.4K
C
Christoph Wanner
H-index: 135 · Papers: 1.3K
P
Peter Rossing
H-index: 120 · Papers: 1.4K
D
Dick de Zeeuw
H-index: 118 · Papers: 1.2K
View more